Multiple Assemblies exist for SMTL entry 2x7o
Crystal structure of TGFbRI complexed with an indolinone inhibitor; X-RAY DIFFRACTION 3.70 Å

SMTL ID
2x7o.1
Ligands
(3Z)-N-ETHYL-N-METHYL-2-OXO-3-(PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]AMINO}METHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-6-CARBOXAMIDE
Polypeptides
TGF-BETA RECEPTOR TYPE I
Oligo-state
monomer
SMTL ID
2x7o.2
Ligands
(3Z)-N-ETHYL-N-METHYL-2-OXO-3-(PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]AMINO}METHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-6-CARBOXAMIDE
Polypeptides
TGF-BETA RECEPTOR TYPE I
Oligo-state
monomer
SMTL ID
2x7o.3
Ligands
(3Z)-N-ETHYL-N-METHYL-2-OXO-3-(PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]AMINO}METHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-6-CARBOXAMIDE
Polypeptides
TGF-BETA RECEPTOR TYPE I
Oligo-state
monomer
SMTL ID
2x7o.4
Ligands
(3Z)-N-ETHYL-N-METHYL-2-OXO-3-(PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]AMINO}METHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-6-CARBOXAMIDE
Polypeptides
TGF-BETA RECEPTOR TYPE I
Oligo-state
monomer
SMTL ID
2x7o.5
Ligands
(3Z)-N-ETHYL-N-METHYL-2-OXO-3-(PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]AMINO}METHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-6-CARBOXAMIDE
Polypeptides
TGF-BETA RECEPTOR TYPE I
Oligo-state
monomer